Substituted bicyclic derivatives useful as anticancer agents
申请人:——
公开号:US20010034351A1
公开(公告)日:2001-10-25
The invention relates to compounds of the formula 1
1
and to pharmaceutically acceptable salts and solvates thereof, wherein A, X, R
1
, R
3
and R
4
are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals with administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
PYRIMIDINE CARBOXAMIDES AS SODIUM CHANNEL BLOCKERS
申请人:LOCKMAN Jeffrey
公开号:US20160009659A1
公开(公告)日:2016-01-14
The present disclosure provides substituted pyrimidine carboxamides of Formula (I) and the pharmaceutically acceptable salts and solvates thereof, wherein A
1
, X, A
2
, W
1
, W
2
, W
3
, E, Z, and R
4
are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.
Pyrimidine carboxamides as sodium channel blockers
申请人:Purdue Pharma L.P.
公开号:US10196364B2
公开(公告)日:2019-02-05
The present disclosure provides substituted pyrimidine carboxamides of Formula (I) and the pharmaceutically acceptable salts and solvates thereof wherein A1, X, A2, W1, W2, W3, E, Z, and R4 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.